Vigilant Capital Management, LLC Eli Lilly & CO Transaction History

Vigilant Capital Management, LLC

$1.34 Billion
Q2 2023

A detailed history of Vigilant Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 3,976 shares of LLY stock, worth $3.16 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

3,976

Previous 4,226 5.92%

Holding current value

$3.16 Million

Previous $1.45 Million 28.46%

% of portfolio

0.14%

Previous 0.12%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $87,685 - $117,245	-250 Reduced 5.92%	3,976 $1.86 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $22,054 - $25,902	71 Added 1.71%	4,226 $1.45 Million
Q4 2022 Jan 26, 2023	BUY	$321.55 - $374.67 $45,981 - $53,577	143 Added 3.56%	4,155 $1.52 Million
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $24,014 - $27,367	81 Added 2.06%	4,012 $1.3 Million
Q2 2022 Jul 06, 2022	BUY	$278.73 - $327.27 $39,300 - $46,145	141 Added 3.72%	3,931 $1.28 Million
Q1 2022 Apr 07, 2022	SELL	$234.69 - $291.66 $46,938 - $58,332	-200 Reduced 5.01%	3,790 $1.09 Million
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $120,328 - $148,081	-543 Reduced 11.98%	3,990 $922,000
Q2 2021 Jul 09, 2021	BUY	$180.55 - $233.54 $16,971 - $21,952	94 Added 2.12%	4,533 $1.04 Million
Q4 2020 Jan 14, 2021	BUY	$130.46 - $172.63 $61,838 - $81,826	474 Added 11.95%	4,439 $749,000
Q1 2020 Apr 17, 2020	SELL	$119.05 - $147.35 $31,191 - $38,605	-262 Reduced 6.2%	3,965 $550,000
Q1 2019 Apr 09, 2019	SELL	$111.31 - $131.02 $81,812 - $96,299	-735 Reduced 14.81%	4,227 $548,000
Q4 2018 Jan 15, 2019	SELL	$105.9 - $118.64 $1.13 Million - $1.27 Million	-10,683 Reduced 68.28%	4,962 $574,000
Q3 2018 Oct 11, 2018	SELL	$85.86 - $107.31 $42,414 - $53,011	-494 Reduced 3.06%	15,645 $1.68 Million
Q4 2017 Jan 31, 2018	BUY	$81.94 - $87.89 $1.32 Million - $1.42 Million	16,139	16,139 $1.36 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.

Account

Vigilant Capital Management, LLC Eli Lilly & CO Transaction History